CVE-2024-45097

CVE-2024-45097 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 5.9. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-436.

Key facts

Description

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user to bypass intended access restrictions and conduct resource modification.

Frequently asked questions

What is CVE-2024-45097?
IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user to bypass intended access restrictions and conduct resource modification.
How severe is CVE-2024-45097?
CVE-2024-45097 has a CVSS 3.x base score of 5.9, rated medium severity. It is exploitable over network with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity high, and availability none.
Is CVE-2024-45097 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (23rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-45097?
CVE-2024-45097 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-45097?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-45097 have an EU (EUVD) identifier?
Yes. CVE-2024-45097 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-41304.
When was CVE-2024-45097 published?
CVE-2024-45097 was published on 2024-09-05 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Aspera Faspex

All CVEs affecting Ibm Aspera Faspex →

Other CWE-436 vulnerabilities

Browse all CWE-436 vulnerabilities →